Expertise in
24
conditions

Dr. Steven W. Ing

Endocrinology
Ohio State Outpatient Care East
543 Taylor Ave, 
Columbus, OH 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
24
conditions
Ohio State Outpatient Care East
543 Taylor Ave, 
Columbus, OH 

Overview

Steven Ing is an Endocrinologist practicing medicine in Columbus, Ohio.

Dr. Ing is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Hypoparathyroidism, Osteoporosis, Postmenopausal Osteoporosis, and Hypophosphatasia (HPP).

He is actively involved in clinical research, co-authoring 46 peer reviewed articles and participating in 5 clinical trials. Dr. Ing is currently accepting new patients.

Specialties

Endocrinology

Licenses

Internal Medicine in OH

Hospital Affiliations

Licking Memorial Hospital
Ohio State University State Health System
Grant Medical Center
Genesis Hospital

Languages Spoken

English
Cantonese

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Ohio State Outpatient Care East
543 Taylor Ave, Columbus, OH 43203

Additional Areas of Focus

Dr. Ing has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
Enrollment Status: Completed
Publish Date: July 14, 2026
Intervention Type: Other
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Biological
Study Drug: rhPTH(1-84)
Study Phase: Phase 4
A Randomized, Double-Blind, Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PCO371 in Patients With Hypoparathyroidism
A Randomized, Double-Blind, Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PCO371 in Patients With Hypoparathyroidism
Enrollment Status: Terminated
Publish Date: June 11, 2021
Intervention Type: Drug
Study Phase: Phase 1
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Enrollment Status: Completed
Publish Date: May 25, 2021
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

46 Total Publications

Burden of disease in US patients with skeletal versus muscular or pain manifestations of hypophosphatasia: An analysis from the Global HPP Registry.
Burden of disease in US patients with skeletal versus muscular or pain manifestations of hypophosphatasia: An analysis from the Global HPP Registry.
Journal: Bone
Published: December 22, 2025
Similar Doctors
Expertise in
10
conditions
Dr. Matthew D. Ringel
Endocrinology
Expertise in
10
conditions
Dr. Matthew D. Ringel
Endocrinology
Referral required

Ohio State Martha Morehouse Outpatient Care

2050 Kenny Rd, 
Columbus, OH 
 (4.0 miles away)
614-293-3890
Languages Spoken:
English
See accepted insurances

Matthew Ringel is an Endocrinologist practicing medicine in Columbus, Ohio. Dr. Ringel is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Medullary Thyroid Carcinoma, Follicular Thyroid Cancer, and Thyroidectomy.

Expertise in
9
conditions
Dr. Fadi A. Nabhan
Endocrinology
Expertise in
9
conditions
Dr. Fadi A. Nabhan
Endocrinology
Referral required
Before you request

Ohio State Martha Morehouse Outpatient Care

2050 Kenny Rd, 
Columbus, OH 
 (4.0 miles away)
614-293-3890
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Fadi Nabhan is an Endocrinologist practicing medicine in Columbus, Ohio. Dr. Nabhan is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, Follicular Thyroid Cancer, and Thyroidectomy. Dr. Nabhan is currently accepting new patients.

Expertise in
6
conditions
Dr. Richard T. Kloos
Endocrinology
Expertise in
6
conditions
Dr. Richard T. Kloos
Endocrinology
Referral required
Before you request

Walgreen CO

456 W 10th Ave, 
Columbus, OH 
 (3.2 miles away)
614-292-3800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Richard Kloos is an Endocrinologist practicing medicine in Columbus, Ohio. Dr. Kloos is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Thyroid Nodule, Thyroid Cancer, Medullary Thyroid Carcinoma, Follicular Thyroid Cancer, and Thyroidectomy. Dr. Kloos is currently accepting new patients.

Frequently Asked Questions about Dr. Steven W. Ing

How do I make an appointment with Dr. Steven W. Ing?

You can book an appointment with Dr. Steven W. Ing by calling their office at 614-688-6400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Steven W. Ing a top-rated expert for Hypoparathyroidism?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steven W. Ing is classified as an Elite expert for Hypoparathyroidism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Steven W. Ing specialize in?

While Dr. Steven W. Ing is a Endocrinology, they have specific expertise in Hypoparathyroidism, Osteoporosis, and Postmenopausal Osteoporosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Steven W. Ing participate in research or clinical trials?

Yes. Dr. Steven W. Ing has published 46 articles and abstracts on conditions like Hypoparathyroidism. You can view a list of Dr. Steven W. Ing's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Steven W. Ing accept my insurance?

Dr. Steven W. Ing accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 614-688-6400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ing's expertise for a condition
ConditionClose
View All 19 Advanced Conditions
View All 41 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile